{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:10:18Z","timestamp":1794651018666,"version":"4.9.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Renal medullary carcinomas (RMCs) and collecting duct carcinomas (CDCs) are rare subsets of lethal high-stage, high-grade distal nephron-related adenocarcinomas with a predilection for the renal medullary region. Recent findings have established an emerging group of fumarate hydratase (FH)-deficient tumors related to hereditary leiomyomatosis and renal cell carcinoma (HLRCC-RCCs) syndrome within this morphologic spectrum. Recently developed, reliable ancillary testing has enabled consistent separation between these tumor types. Here, we present the clinicopathologic features and differences in the morphologic patterns between RMC, CDC, and FH-deficient RCC in consequence of these recent developments. This study included a total of 100 cases classified using contemporary criteria and ancillary tests. Thirty-three RMCs (SMARCB1\/INI1-deficient, hemoglobinopathy), 38 CDCs (SMARCB1\/INI1-retained), and 29 RCCs defined by the FH-deficient phenotype (FH<jats:sup>\u2212<\/jats:sup>\/2SC<jats:sup>+<\/jats:sup> or FH<jats:sup>\u00b1<\/jats:sup>\/2SC<jats:sup>+<\/jats:sup> with <jats:italic toggle=\"yes\">FH<\/jats:italic> mutation, regardless of HLRCC syndromic stigmata\/history) were selected. The spectrum of morphologic patterns was critically evaluated, and the differences between the morphologic patterns present in the 3 groups were analyzed statistically. Twenty-five percent of cases initially diagnosed as CDC were reclassified as FH-deficient RCC on the basis of our contemporary diagnostic approach. Among the different overlapping morphologic patterns, sieve-like\/cribriform and reticular\/yolk sac tumor\u2013like patterns favored RMCs, whereas intracystic papillary and tubulocystic patterns favored FH-deficient RCC. The tubulopapillary pattern favored both CDCs and FH-deficient RCCs, and the multinodular infiltrating papillary pattern favored CDCs. Infiltrating glandular and solid sheets\/cords\/nested patterns were not statistically different among the 3 groups. Viral inclusion\u2013like macronucleoli, considered as a hallmark of HLRCC-RCCs, were observed significantly more frequently in FH-deficient RCCs. Despite the overlapping morphology found among these clinically aggressive infiltrating high-grade adenocarcinomas of the kidney, reproducible differences in morphology emerged between these categories after rigorous characterization. Finally, we recommend that definitive diagnosis of CDC should only be made if RMC and FH-deficient RCC are excluded.<\/jats:p>","DOI":"10.1097\/pas.0000000000001000","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:59:45Z","timestamp":1515376785000},"page":"279-292","source":"Crossref","is-referenced-by-count":126,"title":["Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase\u2013deficient Renal Cell Carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"Chisato","family":"Ohe","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Urology, VCU School of Medicine, Richmond, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Sirohi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Divatia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Houston Methodist Hospital, Weill Medical College of Cornell University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"de Peralta-Venturina","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladell P.","family":"Paner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Friedrich-Alexander-University, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitual B.","family":"Amin","sequence":"additional","affiliation":[{"name":"William Beaumont Hospital, Royal Oak"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[{"name":"Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Colecchia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comp\u00e9rat","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Tenon, Assistance Publique-H\u00f4pitaux de Paris, UPMC Paris VI, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Werneck da Cunha","sequence":"additional","affiliation":[{"name":"Department of Pathology, AC Camargo Cancer Center, S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research Royal North Shore Hospital and University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Hes","sequence":"additional","affiliation":[{"name":"Charles University Hospital, Pilsen, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Jochum","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi P.","family":"Kunju","sequence":"additional","affiliation":[{"name":"Department of Pathology and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[{"name":"Douglass Hanly Moir Pathology, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Nesi","sequence":"additional","affiliation":[{"name":"Division of Pathological Anatomy, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Picken","sequence":"additional","affiliation":[{"name":"Department of Pathology, Loyola University, Maywood, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Rao","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Guilherme","family":"de Oliveira Salles","sequence":"additional","affiliation":[{"name":"Anatomic Pathology, Mario Penna Institute, Hospital Luxemburgo, Belo Horizonte, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Schultz","sequence":"additional","affiliation":[{"name":"Institute of Anatomic Pathology, Piracicaba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[{"name":"Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Tomlins","sequence":"additional","affiliation":[{"name":"Department of Pathology and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Calgary Laboratory Services, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA"},{"name":"Department of Pathology and Laboratory Medicine and Urology, University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R2-20240215","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0090-4295(02)02154-4","article-title":"Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications","volume":"60","author":"Swartz","year":"2002","journal-title":"Urology"},{"key":"R3-20240215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/modpathol.3800934","article-title":"Renal medullary carcinoma: report of seven cases from Brazil","volume":"20","author":"Watanabe","year":"2007","journal-title":"Mod Pathol"},{"key":"R5-20240215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver Classification of renal neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R6-20240215","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.eururo.2007.01.070","article-title":"Collecting duct renal cell carcinoma: a matched analysis of 41 cases","volume":"52","author":"Karakiewicz","year":"2007","journal-title":"Eur Urol"},{"key":"R7-20240215","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/PAS.0b013e3182635954","article-title":"Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma","volume":"36","author":"Gupta","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R9-20240215","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R10-20240215","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R11-20240215","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20240215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R13-20240215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R14-20240215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"R15-20240215","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R16-20240215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","article-title":"Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics","volume":"10","author":"Lehtonen","year":"2011","journal-title":"Fam Cancer"},{"key":"R18-20240215","first-page":"260A","article-title":"Is tubulocystic carcinoma with dedifferentiation a form of HLRCC\/fumarate hydratase-deficient RCC?","volume":"(suppl 2s)","author":"Smith","year":"2015","journal-title":"Mod Pathol"},{"key":"R19-20240215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"suppl 2","key":"R20-20240215","first-page":"211A","article-title":"Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: a comparison of fumarate hydratase (FH) and S-(2-succino)-cysteine (2SC) immunohistochemistry as ancillary tools","volume":"28","author":"Chen","year":"2015","journal-title":"Mod Pathol"},{"key":"R21-20240215","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2559.2011.04093.x","article-title":"p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system","volume":"60","author":"Carvalho","year":"2012","journal-title":"Histopathology"},{"key":"R22-20240215","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/PAS.0000000000000222","article-title":"Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R23-20240215","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R24-20240215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5001\/omj.2010.2","article-title":"A review of clinical profile in sickle cell traits","volume":"25","author":"John","year":"2010","journal-title":"Oman Med J"},{"key":"R25-20240215","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","article-title":"SMARCB1\/INI1 inactivation in renal medullary carcinoma","volume":"61","author":"Calderaro","year":"2012","journal-title":"Histopathology"},{"key":"R26-20240215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAS.0b013e3182770406","article-title":"Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R27-20240215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PAS.0b013e3182417d78","article-title":"Expression of OCT3\/4 in renal medullary carcinoma represents a potential diagnostic pitfall","volume":"36","author":"Rao","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R28-20240215","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1016\/j.urology.2011.04.043","article-title":"Immunohistochemical analysis of SMARCB1\/INI-1 expression in collecting duct carcinoma","volume":"78","author":"Elwood","year":"2011","journal-title":"Urology"},{"key":"R29-20240215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","article-title":"The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity","volume":"21","author":"Agaimy","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"R30-20240215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2017.07.006","article-title":"Renal cell carcinoma, unclassified with medullary phenotype: poorly-differentiated adenocarcinomas overlapping with renal medullary carcinoma","volume":"67","author":"Sirohi","year":"2017","journal-title":"Hum Pathol"},{"key":"R31-20240215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00125480-199703000-00002","article-title":"Collecting duct carcinoma of the kidney","volume":"4","author":"Amin","year":"1997","journal-title":"Adv Anat Pathol"},{"key":"R32-20240215","doi-asserted-by":"crossref","first-page":"34219","DOI":"10.1074\/jbc.M703551200","article-title":"Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress","volume":"282","author":"Nagai","year":"2007","journal-title":"J Biol Chem"},{"key":"R33-20240215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"R34-20240215","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","article-title":"Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients","volume":"39","author":"Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"suppl 2","key":"R35-20240215","first-page":"243A","article-title":"IHC helps to identified renal tumors associated with HLRCC syndrome","volume":"27","author":"Oteri","year":"2014","journal-title":"Mod Pathol"},{"key":"R36-20240215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathol"},{"key":"R37-20240215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/gcc.22452","article-title":"Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma","volume":"56","author":"Vocke","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"R38-20240215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R39-20240215","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0000000000000258","article-title":"Best practices recommendations in the application of immunohistochemistry in the kidney tumors: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Reuter","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R40-20240215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R41-20240215","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study","volume":"22","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"R42-20240215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejso.2004.11.009","article-title":"S100A1 and KIT gene expressions in common subtypes of renal tumours","volume":"31","author":"Li","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R43-20240215","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/modpathol.3800828","article-title":"Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study","volume":"20","author":"Rocca","year":"2007","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:08:27Z","timestamp":1707980907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001000","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}